WT-1-28-z

N/A

Report date: 2023/01/04 15:14:33

Base Information

Drug NameWT-1-28-z
Drug Alias NameWT1-28zWT-1-28-z
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionWilms' Tumour 1 modulators
TargetsWilms' Tumour 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEureka Therapeutics IncMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesEureka Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A